We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking BCAX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
BC

Bicara Therapeutics Inc. (BCAX) short interest & options flow

NASDAQ

Short interest at BCAX stands at 18.4% of free float. Stock down 48% over one month.

Latest pulse4d ago

BCAX Goldman Sachs downgrades to Sell, slashes target 60% to $8 from $20.

Short interest at BCAX stands at 18.4% of free float. Stock down 48% over one month.

$7.93-13.14% 1d-53.05% 1w-55.02% 1mClose: 2 Nov 2026
Short interest % of float
High
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Availability
Rising
Live availability on ORTEX →
Market cap
$604M
Next earnings
9 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 3 Nov 2026

ORTEX chart of Bicara Therapeutics Inc. (BCAX) share price and short interest (% of free float), six months to November 2, 2026

Latest signals on BCAX

  • Analyst

    BCAX Goldman Sachs downgrades to Sell, slashes target 60% to $8 from $20.

  • Options

    BCAX put-call ratio crashes to 0.52, down 4.15 standard deviations from its 20-day mean of 0.79, signaling extreme call buying.

BCAX news and analysis

RSS

No long-form analysis yet for BCAX. Pulse alerts and the live data picture are available on ORTEX.

Open BCAX on ORTEX →

Want the live picture for BCAX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BCAX — free to start on ORTEX.

Sign up for free →Open BCAX on ORTEX